Teva and Medincell's schizophrenia drug meets main goal of late-stage study
(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their injectable form of a schizo...
4h ago
Europe in whooping cough epidemic as cases soar, says health agency
LONDON (Reuters) - Countries across Europe reported a huge rise in whooping cough cases in 2023 and the first three months of...
6h ago
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
(Reuters) - McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for th...
17h ago
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
(Reuters) - Diagnostics firm Bio Rad Laboratories reiterated its 2024 sales growth forecast on Tuesday, weighed by persistent...
17h ago
Pfizer reports patient death in Duchenne gene therapy study
(Reuters) - A young boy died due to a cardiac arrest in a mid-stage trial that tested Pfizer's experimental gene therapy for ...
18h ago
Idaho will seek to revive 'abortion trafficking' law in US appeals court
By Brendan Pierson (Reuters) - Idaho will urge a federal appeals court on Tuesday to revive a 2023 law making it a crime to h...
19h ago
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports
(Reuters) - Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid vaccine worldwide, The Telegraph reported on Tuesday...
19h ago
Bankrupt Steward Health puts its hospitals up for sale, discloses $9 billion in debt
By Dietrich Knauth NEW YORK (Reuters) - Bankrupt Steward Health Care has put all of its 31 U.S. hospitals up for sale, hoping...
20h ago
Florida sues Biden administration over new transgender healthcare rule
By Brendan Pierson (Reuters) - Florida's top prosecutor and a Catholic medical group on Tuesday sued the Biden administration...
23h ago
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10
(Reuters) - Eli Lilly said on Tuesday a panel of independent U.S. FDA advisers will discuss whether the agency should approve...
May 07, 2024